Cogstate (CGS) is held by 1 ASX ETF as of 15 Oct 2026. It weighs most in ATEC, at 0.3% of the fund. Over the last year it rose 35.8%: on $10,000, +$3577. We explain 7 big moves in that time.
About CGS
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$648.9m
- Held by1 ETF
- Big moves7 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +10.1%peak +15.4%12 Oct 2026· Operational
Cogstate released a market-sensitive quarterly business update that appears to have contained positive news, driving the stock up nearly 15%.
- +4.3%peak +6.1%18 Sep 2026· Unknown
CGS likely rose on retail investor and media attention after being featured in penny stock and growth stock articles, with no company announcement to explain the move.
- +5.1%peak +6.5%20 Aug 2026· Sector Flow
CGS.AX rose sharply alongside a broad and strong rally in the ASX healthcare sector, which gained over 10% on the same day.
- −2.2%peak −6.1%18 Aug 2026· Earnings Beat
Cogstate shares fell sharply as investors sold after the company reported strong FY26 results, a classic 'sell the news' reaction to an earnings release that had likely been priced in.
- +7.1%peak +8.2%9 Jul 2026· Contract
Cogstate's stock surged after reporting US$89 million in net sales contracts for FY26, reassuring investors that earlier half-year concerns were overblown, with a broker also flagging 37% upside potential.
- +7.7%11 Jun 2026· Analyst
CogState shares rose following a positive analyst coverage highlighting a 27% upside and a consensus Buy rating, driven by an Alzheimer's clinical trial surge.
- −12.0%10 Dec 2025· Guidance Down
Cogstate shares plunged after announcing a timing delay in expected revenue, cutting current-year guidance.
Held by 1 ETF
Of every $10,000 in each fund, how much is in CGS today.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did CGS fall 10.5% on 2 Sep 2024?
Cogstate
No specific news was identified to explain the 10.5% drop in Cogstate's share price, but the move suggests a negative company-specific event, likely an earnings miss or guidance downgrade.
The fall was large and high-volume, indicating a significant negative catalyst, but no news articles were found. Given Cogstate's cyclical revenue and dependence on clinical trial activity, an earnings or outlook disappointment is plausible, but there is insufficient evidence to confirm.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
No evidence layer produced anything for this event.
What it did to the 1 ETF holding CGS
On $10,000 in each fund, at the weight it holds today